Immune checkpoint inhibitors‐induced neuromuscular toxicity: From pathogenesis to treatment
Dimitri Psimaras(Université Claude Bernard Lyon 1), Andreas A. Argyriou(Agios Andreas Hospital), Roser Velasco(Universitat Autònoma de Barcelona), Jordi Bruna(Universitat Autònoma de Barcelona), Maryam B. Lustberg(Yale Cancer Center), Stefano Tamburin(University of Verona), Cristina Birzu(Centre National de la Recherche Scientifique)
Cited by 90
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296